Search results for:
budesonide-formoterol
budesonide-formoterol
| Drug Name |
Form |
Strength |
Ambulatory Use Only |
Ambulatory Restrictions |
Inpatient Restrictions |
Non-Formulary |
| Symbicort |
AEROSOL, INHALATION |
80 mcg-4.5 mcg/inh; 160 mcg-4.5 mcg/inh |
|
|
|
|
Last updated: Jan. 7, 2026
Therapeutic Alternative:
RESPIRATORY (ICS/LABA)
Ordered Drug
Therapeutic
Alternate
Fluticasone / vilanterol (Breo Ellipta)
Mometasone / formoterol (Dulera)**
Fluticasone / salmeterol (Advair) MDI
Fluticasone / salmeterol (Advair; Wixela) Diskus
Fluticasone / salmeterol (AirDuo Respiclick) MDPI
Budesonide / formoterol (Symbicort) HFA
100 mcg/25 mcg, 1 inhalation daily
100 mcg/5 mcg, 2 inhalations twice daily
45 mcg/21 mcg, 2 inhalations twice daily
100 mcg/50 mcg, 1 inhalation twice daily
55 mcg/14 mcg, 1 inhalation twice daily
80 mcg/4.5 mcg, 2 inhalations twice daily
200 mcg/25 mcg, 1 inhalation daily
200 mcg/5 mcg, 2 inhalations twice daily
115 mcg/21 mcg, 2 inhalations twice daily
AND
230 mcg /21 mcg, 2 inhalations twice daily
250 mcg/50 mcg, 1 inhalation twice daily
AND
500 mcg/50 mcg, 1 inhalation BID
113 mcg/14 mcg, 1 inhalation twice daily
AND
232 mcg/14 mcg, 1 inhalation twice daily
160 mcg/4.5 mcg, 2 inhalations twice daily
** Patients on ritonavir or cobicistat are excluded from this substitution. If on Dulera® therapy at home, use either the home medication or the non-formulary request processes.